A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Public ClinicalTrials.gov record NCT07332000. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Biomarker Study in Men With Localized, Favorable, Intermediate-risk Prostate Cancer Treated With Aglatimagene Besadenovec
Study identification
- NCT ID
- NCT07332000
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Candel Therapeutics, Inc.
- Industry
- Enrollment
- 45 participants
Conditions and interventions
Interventions
- aglatimagene besadenovec + valacyclovir Biological
- External Beam Radiation Therapy (EBRT) Radiation
Biological · Radiation
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2025
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
- Last update posted
- Mar 19, 2026
2025 – 2026
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Academic Urology and Urogynecology of Arizona | Peoria | Arizona | 85381 | Recruiting |
| Colorado Clinical Research | Lakewood | Colorado | 80228 | Recruiting |
| Urology Associates | Littleton | Colorado | 80122 | Recruiting |
| Chesapeake Urology Research Associates | Towson | Maryland | 21204 | Recruiting |
| Sheldon Freedman, MD Ltd. | Las Vegas | Nevada | 89144 | Recruiting |
| Summit Health | Saddle Brook | New Jersey | 07663 | Recruiting |
| START Carolinas | Myrtle Beach | South Carolina | 29572 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07332000, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07332000 live on ClinicalTrials.gov.